STOCK TITAN

Emerson's Next-Generation Software Streamlines Pharmaceutical Development, Accelerates Speed to Market

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
Emerson introduces DeltaV Workflow Management, a next-generation software for life sciences companies, streamlining pharmaceutical development and accelerating speed to market. The software offers scalable options for smaller innovators, providing a cloud-based solution for recipe authoring, execution, and data capture. It simplifies the drug development process, reduces timeline to days, and enhances regulatory compliance.
Positive
  • DeltaV Workflow Management simplifies recipe workflow data, transitioning from manual records to digital format.
  • The software accelerates drug development timelines by reducing the time needed for recipe creation and automation.
  • Emerson's new software enhances regulatory compliance by allowing users to add quality control parameters and e-signature requirements.
  • DeltaV Workflow Management minimizes contamination risks associated with paper records in sterile clean rooms.
  • Users can create digital batch records, automate workflows, and meet Good Manufacturing Practice standards with simple drag-and-drop elements.
  • The software provides additional flexibility for digital recipe development and execution, complementing Emerson's existing manufacturing execution solutions.
  • Emerson's commitment to enhancing and investing in manufacturing execution solutions for organizations of any scale is evident in the introduction of DeltaV Workflow Management.
Negative
  • None.

DeltaV Workflow Management delivers scalable recipe authoring and execution technologies for life sciences companies

ST. LOUIS, April 16, 2024 /PRNewswire/ -- Global automation technology and software leader Emerson (NYSE: EMR) today introduced DeltaV™ Workflow Management, a next-generation software designed for life sciences companies in early-stage development. The new software continues Emerson's expansion of capabilities of the evolving DeltaV automation platform to offer more scalable options to suit the needs of smaller life sciences innovators. For companies with limited IT infrastructure, DeltaV Workflow Management provides a cloud-based, software-as-a-service solution for simple recipe authoring, execution and electronic data capture.

In high-growth life sciences companies, such as those making advanced therapy medicinal products for hard-to-treat diseases and personalized medicines, manufacturing facilities still heavily rely on manual processes and record-keeping for bench-scale operations and recipe authoring. Many do not have robust IT departments, nor staff experienced in the complex coding necessary with traditional manufacturing execution systems.

DeltaV Workflow Management removes this layer of complexity by transitioning recipe workflow data from manual records to digital "paper on glass," providing a simple and scalable solution that helps accelerate the drug development process with no coding experience required. The software also generates searchable digital records that are easily organized and exported and data that can be more easily analyzed and reported. In addition, this digital shift minimizes the contamination risks associated with paper records in sterile clean rooms.

"DeltaV Workflow Management enables innovation for both startups and established labs that demand speed and simplicity in early-stage drug development," said Nathan Pettus, president of Emerson's process systems and solutions business. "Recipes relying on standard, full-blown manufacturing execution systems can take years of experience and months to create and fully automate. With this new software, the timeline is reduced to days, providing companies with a head start toward commercialization and getting new therapeutic medicines into the pipeline faster."

Within DeltaV Workflow Management, users employ simple drag-and-drop elements to create steps for a recipe and automate workflows that meet Good Manufacturing Practice standards. Within those steps, they can add new parameters and e-signature requirements for quality control and regulatory compliance, run product recipes, authorize users for specific tasks and create digital batch records.  

DeltaV Workflow Management expands and complements the user options for digital recipe development and execution already provided by Emerson's DeltaV MES—the newest evolution of the Syncade MES. Users now have additional flexibility to match digital recipe solutions to their business needs, underscoring Emerson's commitment to continuing enhancement of and investment in a portfolio of manufacturing execution solutions for organizations at any scale.

About Emerson 
Emerson (NYSE: EMR) is a global technology and software company providing innovative solutions for the world's essential industries. Through its leading automation portfolio, including its majority stake in AspenTech, Emerson helps hybrid, process and discrete manufacturers optimize operations, protect personnel, reduce emissions and achieve their sustainability goals. For more information, visit Emerson.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/emersons-next-generation-software-streamlines-pharmaceutical-development-accelerates-speed-to-market-302115695.html

SOURCE Emerson

FAQ

What is the name of the next-generation software introduced by Emerson for life sciences companies?

Emerson introduced DeltaV Workflow Management.

What does DeltaV Workflow Management provide for companies with IT infrastructure?

DeltaV Workflow Management provides a cloud-based, software-as-a-service solution for simple recipe authoring, execution, and electronic data capture.

How does DeltaV Workflow Management simplify the drug development process?

The software transitions recipe workflow data from manual records to digital format, reducing the time needed for recipe creation and automation.

What benefits does DeltaV Workflow Management offer in terms of regulatory compliance?

The software allows users to add quality control parameters, e-signature requirements, and create digital batch records to enhance regulatory compliance.

What risks does DeltaV Workflow Management help minimize in manufacturing facilities?

The software minimizes contamination risks associated with paper records in sterile clean rooms.

How can users meet Good Manufacturing Practice standards using DeltaV Workflow Management?

Users can create digital batch records, automate workflows, and meet Good Manufacturing Practice standards with simple drag-and-drop elements.

What flexibility does DeltaV Workflow Management provide for digital recipe development and execution?

The software offers additional flexibility for digital recipe development and execution, complementing Emerson's existing manufacturing execution solutions.

What does the introduction of DeltaV Workflow Management reflect about Emerson's commitment?

The introduction of DeltaV Workflow Management reflects Emerson's commitment to enhancing and investing in manufacturing execution solutions for organizations of any scale.

Emerson Electric Co.

NYSE:EMR

EMR Rankings

EMR Latest News

EMR Stock Data

60.83B
569.00M
0.35%
77.24%
1.05%
Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables
Manufacturing
Link
United States of America
ST LOUIS

About EMR

at emerson, we’re passionate about what we do. by fusing decades of technology and engineering expertise, we continue to solve some of the world’s most complex challenges with integrated, innovative solutions. we recruit the greatest talent and apply the best technologies to benefit our customers worldwide. our goal is to design and produce products, systems and solutions that harness the needs of our customers in unique ways, and deliver unmatched value. with more than 135,000 employees and 235 manufacturing locations, emerson has a wide range of industry knowledge, manufacturing expertise, and technological innovation, around the world. join our next generation of leaders now.